Centiva Capital’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.43M Buy
38,567
+1,067
+3% +$231K 0.07% 196
2026
Q1
$7.81M Buy
+37,500
New +$6.88M 0.06% 214
2025
Q3
Sell
-17,043
Closed -$2.51M 1774
2025
Q2
$2.51M Buy
17,043
+8,000
+88% +$946K 0.04% 284
2025
Q1
$1.02M Buy
+9,043
New +$1.22M 0.03% 490
2024
Q2
Sell
-5,086
Closed -$731K 2471
2024
Q1
$731K Buy
+5,086
New +$674K 0.02% 814
2023
Q4
Sell
-4,377
Closed -$507K 2199
2023
Q3
$507K Buy
4,377
+2,317
+112% +$320K 0.01% 947
2023
Q2
$325K Sell
2,060
-6,944
-77% -$1.05M 0.01% 1074
2023
Q1
$1.58M Buy
9,004
+7,000
+349% +$1.18M 0.04% 478
2022
Q4
$272K Sell
2,004
-6,103
-75% -$802K 0.01% 991
2022
Q3
$1M Buy
+8,107
New +$1.08M 0.02% 624
2021
Q4
Sell
-29,043
Closed -$4.07M 1509
2021
Q3
$4.07M Buy
29,043
+27,714
+2,085% +$4.16M 0.26% 87
2021
Q2
$204K Buy
+1,329
New +$186K ﹤0.01% 1212

Other funds holding SLAB

Centiva Capital's SLAB Position: Q2 2026 in Review

Centiva Capital increased its Silicon Laboratories (SLAB) stake by 2.8% in Q2 2026, buying an estimated $231K and bringing the position to 38,567 shares worth $8.43M. The position accounts for 0.07% of the portfolio, ranked #196.

Centiva Capital first reported a position in SLAB in Q2 2021 and has held it in 12 quarters since. 352 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Centiva Capital held 38,567 shares of Silicon Laboratories worth $8.43M as of Q2 2026.
  • Centiva Capital bought 1,067 Silicon Laboratories shares in Q2 2026, an estimated $231K.
  • Silicon Laboratories made up 0.07% of Centiva Capital's portfolio in Q2 2026, its #196 holding.
  • Centiva Capital first reported a position in Silicon Laboratories in Q2 2021 and has held it in 12 quarters since.
  • 352 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.